NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.

Journal Article (Journal Article)

The NCCN Guidelines for Prostate Cancer address staging and risk assessment after a prostate cancer diagnosis and include management options for localized, regional, recurrent, and metastatic disease. The NCCN Prostate Cancer Panel meets annually to reevaluate and update their recommendations based on new clinical data and input from within NCCN Member Institutions and from external entities. These NCCN Guidelines Insights summarizes much of the panel's discussions for the 4.2022 and 1.2023 updates to the guidelines regarding systemic therapy for metastatic prostate cancer.

Full Text

Duke Authors

Cited Authors

  • Schaeffer, EM; Srinivas, S; Adra, N; An, Y; Barocas, D; Bitting, R; Bryce, A; Chapin, B; Cheng, HH; D'Amico, AV; Desai, N; Dorff, T; Eastham, JA; Farrington, TA; Gao, X; Gupta, S; Guzzo, T; Ippolito, JE; Kuettel, MR; Lang, JM; Lotan, T; McKay, RR; Morgan, T; Netto, G; Pow-Sang, JM; Reiter, R; Roach, M; Robin, T; Rosenfeld, S; Shabsigh, A; Spratt, D; Teply, BA; Tward, J; Valicenti, R; Wong, JK; Berardi, RA; Shead, DA; Freedman-Cass, DA

Published Date

  • December 2022

Published In

Volume / Issue

  • 20 / 12

Start / End Page

  • 1288 - 1298

PubMed ID

  • 36509074

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2022.0063


  • eng

Conference Location

  • United States